Skip to main content
Download PDF
- Main
ReACT: Overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma.
- Reardon, David A;
- Schuster, James;
- Tran, David Dinh;
- Fink, Karen L;
- Nabors, Louis B;
- Li, Gordon;
- Bota, Daniela Annenelie;
- Lukas, Rimas Vincas;
- Desjardins, Annick;
- Ashby, Lynn Stuart;
- Duic, J Paul;
- Mrugala, Maciej M;
- Werner, Andrea;
- Hawthorne, Thomas;
- He, Yi;
- Green, Jennifer A;
- Yellin, Michael Jay;
- Turner, Christopher D;
- Davis, Thomas A;
- Sampson, John H
- et al.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%